DROR

SEC source: 0001213900-24-055836 · ownership.xml · derivative · entry 1

Shvets Moshe · CIK 0001993398 · Director · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,578,694

Underlying: Common Stock · 57,578,694 shares

Expires 2034-06-17

F1 · derivative.exercise_date: The stock options vested two-thirds upon the date of grant, and the remainder vests on December 6, 2024, subject to earlier vesting upon the achievement of patient use objectives, provided the Reporting Person is employed by or providing services to the Issuer or an affiliate on the applicable vesting date.

SEC source: 0001213900-24-055833 · ownership.xml · derivative · entry 1

Haddad Eliyahu · CIK 0001994035 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,965,715

Underlying: Common Stock · 95,965,715 shares

Expires 2034-06-17

F1 · derivative.exercise_date: The stock options vested two-thirds upon the date of grant, and the remainder vests on December 6, 2024, subject to earlier vesting upon the achievement of patient use objectives, provided the Reporting Person is employed by or providing services to the Issuer or an affiliate on the applicable vesting date.

SEC source: 0001213900-24-055839 · ownership.xml · derivative · entry 1

Englander Yehuda · CIK 0001993585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,597,675

Underlying: Common Stock · 9,597,675 shares

Expires 2034-06-17

F1 · derivative.exercise_date: The stock options vested two-thirds upon the date of grant, and the remainder vests on June 1, 2025, provided the Reporting Person is employed by or providing services to the Issuer or an affiliate.

SEC source: 0001213900-24-055829 · ownership.xml · derivative · entry 1

Hurvitz Chaim · CIK 0001630542 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,122,239

Underlying: Common Stock · 21,122,239 shares

Expires 2034-06-17

F1 · derivative.exercise_date: The stock options vested fully upon the date of grant.

SEC source: 0001387131-23-011683 · haddad-form4_091323.xml · derivative · entry 2

Haddad Eliyahu · CIK 0001994035 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,454,545

Underlying: Common Stock · 45,454,545 shares

Expires not disclosed

F3 · derivative.exercise_date: Warrants will be exercisable from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the warrants (the "Initial Exercise Date").

F4 · derivative.expiration_date: Warrants expire on the fifth anniversary of the Initial Exercise Date.

SEC source: 0001387131-23-011683 · haddad-form4_091323.xml · derivative · entry 1

Haddad Eliyahu · CIK 0001994035 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 454,545.45

Underlying: Common Stock · 45,454,545 shares

Expires not disclosed

F1 · derivative.exercise_date: Shares of Series A Convertible Preferred Stock, par value $0.0001 per share and with a stated value of $1.10 per share (the "Preferred Stock") of Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) (the "Company") shall be convertible, at any time and from time to time at the option of the Holder thereof, into shares of the company's common stock, par value $0.0001 per share (the "Common Stock") from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the Preferred Stock.

F2 · derivative.expiration_date: The Preferred Stock is perpetual and therefore has no expiration date.

SEC source: 0001387131-23-011680 · shvets_form4-092723.xml · derivative · entry 2

Shvets Moshe · CIK 0001993398 · Director · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,141,712

Underlying: Common Stock · 26,141,712 shares

Expires not disclosed

F6 · price: Pursuant to a Warrant Exchange Agreement, dated August 14, 2023, between the Company and the reporting person, simultaneously with the Share Exchange, warrants to purchase 7,109 ordinary shares of Private Dror, representing all warrants to purchase ordinary shares of Private Dror held by the reporting person, were cancelled, and the Company issued to the reporting person warrants to purchase shares of the Company's Common Stock with an exercise price of $0.033 per share (the "Warrant Exchange").

F4 · derivative.exercise_date: Warrants will be exercisable from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the warrants (the "Initial Exercise Date").

F5 · derivative.expiration_date: Warrants expire on the fifth anniversary of the Initial Exercise Date.

SEC source: 0001387131-23-011680 · shvets_form4-092723.xml · derivative · entry 1

Shvets Moshe · CIK 0001993398 · Director · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 691,620.94

Underlying: Common Stock · 69,162,094 shares

Expires not disclosed

F3 · price: Pursuant to a Share Exchange Agreement, dated July 5, 2023 (as amended, the "Share Exchange Agreement"), by and among the Company, Dror Ortho-Design Ltd. ("Private Dror"), and the shareholders of Private Dror, the reporting person transferred 18,808 ordinary shares of Private Dror, representing all ordinary shares of Private Dror held by the reporting person, to the Company in exchange for shares of Preferred Stock (the "Share Exchange").

F1 · derivative.exercise_date: Shares of Series A Convertible Preferred Stock, par value $0.0001 per share and with a stated value of $1.10 per share (the "Preferred Stock") of Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) (the "Company") shall be convertible, at any time and from time to time at the option of the Holder thereof, into shares of the company's common stock, par value $0.0001 per share (the "Common Stock") from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the Preferred Stock.

F2 · derivative.expiration_date: The Preferred Stock is perpetual and therefore has no expiration date.

SEC source: 0001387131-23-011681 · ravad_form4-092723.xml · derivative · entry 2

Ravad Chaim · CIK 0001993628 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 228,251,826

Underlying: Common Stock · 228,251,826 shares

Expires not disclosed

F6 · price: Pursuant to a Warrant Exchange Agreement, dated August 14, 2023, between the Company and the reporting person, simultaneously with the Share Exchange, warrants to purchase 62,071 ordinary shares of Private Dror, representing all warrants to purchase ordinary shares of Private Dror held by the reporting person, were cancelled, and the Company issued to the reporting person warrants to purchase shares of the Company's Common Stock with an exercise price of $0.033 per share (the "Warrant Exchange").

F4 · derivative.exercise_date: Warrants will be exercisable from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the warrants (the "Initial Exercise Date").

F5 · derivative.expiration_date: Warrants expire on the fifth anniversary of the Initial Exercise Date.

SEC source: 0001387131-23-011681 · ravad_form4-092723.xml · derivative · entry 1

Ravad Chaim · CIK 0001993628 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,150,945.54

Underlying: Common Stock · 215,094,554 shares

Expires not disclosed

F3 · price: Pursuant to a Share Exchange Agreement, dated July 5, 2023 (as amended, the "Share Exchange Agreement"), by and among the Company, Dror Ortho-Design Ltd. ("Private Dror"), and the shareholders of Private Dror, the reporting person transferred 58,493 ordinary shares of Private Dror, representing all ordinary shares of Private Dror held by the reporting person, to the Company in exchange for shares of Preferred Stock (the "Share Exchange").

F1 · derivative.exercise_date: Shares of Series A Convertible Preferred Stock, par value $0.0001 per share and with a stated value of $1.10 per share (the "Preferred Stock") of Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) (the "Company") shall be convertible, at any time and from time to time at the option of the Holder thereof, into shares of the company's common stock, par value $0.0001 per share (the "Common Stock") from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the Preferred Stock.

F2 · derivative.expiration_date: The Preferred Stock is perpetual and therefore has no expiration date.

SEC source: 0001387131-23-011682 · hurvitz_form4-092723.xml · derivative · entry 2

Hurvitz Chaim · CIK 0001630542 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 42,417,309

Underlying: Common Stock · 42,417,309 shares

Expires not disclosed

F7 · price: Pursuant to a Warrant Exchange Agreement, dated August 14, 2023, between the Company and the reporting person, simultaneously with the Share Exchange, warrants to purchase 7,109 ordinary shares of Private Dror held by Shirat Hachaim, representing all warrants to purchase ordinary shares of Private Dror beneficially owned by the reporting person, were cancelled, and the Company issued to Shirat Hachaim warrants to purchase shares of the Company's Common Stock with an exercise price of $0.033 per share.

F5 · derivative.exercise_date: Warrants will be exercisable from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the warrants (the "Initial Exercise Date").

F6 · derivative.expiration_date: Warrants expire on the fifth anniversary of the Initial Exercise Date.

F4 · ownership.nature: The securities are held by Shirat Hachaim, an entity of which the reporting person is the sole owner and over whose shares the reporting person has sole voting and dispositive power .

SEC source: 0001387131-23-011682 · hurvitz_form4-092723.xml · derivative · entry 1

Hurvitz Chaim · CIK 0001630542 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 592,150.79

Underlying: Common Stock · 59,215,079 shares

Expires not disclosed

F3 · price: Pursuant to a Share Exchange Agreement, dated July 5, 2023 (as amended, the "Share Exchange Agreement"), by and among the Company, Dror Ortho-Design Ltd. ("Private Dror"), and the shareholders of Private Dror, Shirat Hachaim Ltd ("Shirat Hachaim") transferred 16,103 ordinary shares of Private Dror, representing all ordinary shares of Private Dror beneficially owned by the reporting person, to the Company in exchange for shares of Preferred Stock (the "Share Exchange").

F1 · derivative.exercise_date: Shares of Series A Convertible Preferred Stock, par value $0.0001 per share and with a stated value of $1.10 per share (the "Preferred Stock") of Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) (the "Company") shall be convertible, at any time and from time to time at the option of the Holder thereof, into shares of the company's common stock, par value $0.0001 per share (the "Common Stock") from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the Preferred Stock.

F2 · derivative.expiration_date: The Preferred Stock is perpetual and therefore has no expiration date.

F4 · ownership.nature: The securities are held by Shirat Hachaim, an entity of which the reporting person is the sole owner and over whose shares the reporting person has sole voting and dispositive power .